An editor and writer specialising in pharma, biotech and healthcare, Dominic Tyer is pharmaphorum's creative and editorial director and interim managing editor.
Rob Barker has been promoted to chief executive officer of Marlow, UK-based OPEN Health Group after serving as CEO of its Medical Communications practice for the last five years.
In the hours after Pfizer’s momentous vaccine news emerged on Monday #pfizerproud popped up on my social media feeds again and again from the firm’s employees, both past and present.
GlaxoSmithKline’s Nucala (mepolizumab) last month became the first and only biologic treatment approved in the US for Hypereosinophilic Syndrome (HES).
The third episode of Kantar's Health Heroes podcast looks at the effects of increased anxiety on patients’ attitudes and behaviours during the pandemic and how approaches to mental health i
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year
